InvestLog
GMAB logo

GMAB

Genmab A/SNASDAQHealthcare
$27.50+1.03%ClosedMarket Cap: $16.98B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-02-23Guggenheim—Buy—
2026-02-18HC Wainwright & Co.—Buy—
2025-11-10HC Wainwright & Co.—Buy—
2025-11-07Truist Securities—Buy—
2025-10-02HC Wainwright & Co.—Buy—
2025-09-24Guggenheim—Buy—
2025-08-15HC Wainwright & Co.—Buy—
2025-07-08Truist Securities—Buy—
2025-05-13HC Wainwright & Co.—Buy—
2025-04-09HC Wainwright & Co.—Buy—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$1.80$5.10B7
Sun Dec 31$2.59$6.14B10
Mon Dec 31$2.42$6.18B4
Tue Dec 31$2.68$6.51B4